Anthropic Pushes IPO Filing to Late September, Eyeing Mid-October Marketing Launch

Anthropic's journey toward a public listing appears to be stretching beyond what many market participants had anticipated. Rather than filing its IPO prospectus as soon as this week, the company is now aiming for late September, with marketing activities potentially commencing in mid-October at the soonest, according to individuals with knowledge of the situation who spoke with Reuters. This revised schedule could result in an actual listing occurring just before November's U.S. midterm elections.

While the timeline remains subject to change, the significance of this offering cannot be overstated. Discussions among certain investors have centered on a potential valuation in the neighborhood of $2 trillion, which would establish Anthropic's public debut as a crucial indicator of investor appetite for the expansion prospects offered by major artificial intelligence enterprises.

A valuation at that level would position Anthropic among the most substantial companies to debut on public markets at such a scale. This would rank the offering among history's most ambitious IPOs and serve as a pivotal test regarding whether public market participants remain prepared to assign enormous valuations to rapidly expanding AI businesses.

A major financing piece comes first

Before moving forward with its public offering, Anthropic is in the process of securing a $15 billion revolving credit facility, according to the sources. Following completion of this financing arrangement, banking analysts participating in the transaction are anticipated to convene with Anthropic's leadership.

In typical circumstances, companies observe a gap of several weeks between such analyst sessions and the formal public filing of an IPO prospectus. However, Anthropic may compress this timeline given that the banking community already possesses substantial familiarity with the company's operations and strategy, Reuters noted. Among the financial institutions handling the IPO are Morgan Stanley, Goldman Sachs, JPMorgan, and Citi.

The magnitude of this prospective offering distinguishes Anthropic even within the contemporary AI landscape. Certain investors have proposed a valuation around $2 trillion, which exceeds the $1.77 trillion valuation at which SpaceX entered public markets in June.

This valuation expectation relies substantially on Anthropic's anticipated expansion trajectory. According to two individuals acquainted with the company's financial projections, as reported by BigGo Finance, Anthropic is projecting revenue between roughly $190 billion and $200 billion for 2028. The reliance on future revenue figures to support such an enormous valuation underscores a fundamental question for market participants: whether Anthropic's anticipated expansion is carrying most of the valuation burden rather than its present-day business performance.

Why the prospectus matters more than the delay

The adjusted timetable should not necessarily be interpreted as a sign of underlying problems. A more compelling interpretation is that Anthropic is leveraging the additional time to synchronize its financing arrangements and IPO procedures before entering a marketplace prepared to examine every detail.

This approach could render the prospectus itself more consequential than any postponement. Shareholders will need to assess whether Anthropic's growth projections substantiate a valuation approaching $2 trillion, particularly as competitive pressures in the AI sector continue to mount.

For investors participating in public markets, the offering represents more than simply an opportunity to acquire shares in the organization behind Claude. It may emerge as an initial public examination of Wall Street's valuation of the AI expansion narrative when those projections must be reflected in equity pricing.

Anthropic's IPO could therefore represent among the most transparent comparisons yet between the expectations embedded in private AI valuations and the discipline applied by public market investors. The central question will transcend mere investor interest in Claude exposure, instead focusing on the price investors are prepared to accept today for earnings and revenue streams potentially materializing years into the future.